General Information
Revision date
2018-01-03
Product name
Etoricoxib
CAS No.
202409-33-4
Manufacturer Name
BioVision, Inc
Icons in SDS
Company Information
company name
BioVision, Inc
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H310
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
NFPA Rating Product Name/Chemical Name Description Volume Safety Information Etoricoxib Solid B1983-10: 10mg See below B1983-50: 50mg Etoricoxib: Emergency Overview:
2.1 Classification of the substance or mixture
Acute toxicity, Oral (Category 4), H302 Acute toxicity, Dermal (Category 2), H310
Signal word
Danger
Hazard statements
H302 Harmful if swallowed. H310 Fatal in contact with skin.
Precautionary statements
P262 Do not get in eyes, on skin, or on clothing. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P280 Wear protective gloves/ protective clothing. P301 + P312 IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. P302 + P350 IF ON SKIN: Gently wash with plenty of soap and water. P310 Immediately call a POISON CENTER/doctor. P322 Specific measures (see supplemental first aid instructions on this label). P330 Rinse mouth. P361 Remove/Take off immediately all contaminated clothing. P363 Wash contaminated clothing before reuse. P405 Store locked up. P501 Dispose of contents/ container to an approved waste disposal plant.
Health hazards
3 Flammability: 0 3 Fire: 0 Reactivity Hazard: 0
Physical hazards
0
Potential health effects
Inhalation: May be harmful if inhaled. May cause respiratory tract irritation. Skin: Harmful if absorbed through skin. May cause skin irritation. Eyes: Cause eye irritation. Ingestion: Harmful if swallowed.
